Genvor Inc GNVR

$0.75 0.00 (—)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
13,700
Avg volume
5,150
Day's range
$0.65 – $0.75
Shares out
—
Stochastic %K
52%
Beta
—
Analysts
—
Price target
—

Price

Company profile

Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canla...

Show more

Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization. Genvor Incorporated is based in Henderson, Nevada.

Industry
Agricultural Inputs
Sector
Basic Materials
Phone
715 903 6473
Website
https://www.genvor.com
Address
1550 W Horizon Ridge Pkwy, Ste R #3040, Henderson, United States

Latest news

No headlines yet.